NSEGeneral Updates4d ago · 18 Jul 2026, 05:01 pm
General Updates
Rossari Biotech Limited · ROSSARI
✦ AI SummaryResults
Rossari Biotech Limited has announced the outcome of its Board meeting, which approved unaudited financial results for the quarter ended June 30, 2026, grant of options under the Rossari Employee Stock Option Plan - 2019, allotment of equity shares under the same plan, and transfer of 100% shareholding of Rossari International Limited Company to Rossari (Singapore) Pte. Ltd.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.
Attachments (1)
📄pdf
Download →
ROSSARI_18072026170114_20260718_Outcome_of_Board_Meeting.pdf
View document text
ROSSARI
making you more competitive
July 18, 2026
DCS-CRD Listing Compliance
BSE Limited National Stock Exchange of India Limited
First Floor, New Trade Wing Exchange Plaza, 5th Floor
Rotunda Building, Phiroze Jeejeebhoy Towers Plot No. C/1, ‘G’ Block, Bandra- Kurla Complex
Dalal Street, Fort Mumbai 400001 Bandra East Mumbai 400051
Fax No.2272 3121/2037/2039 Fax No.2659 8237/8238
Stock Code: 543213 Stock Code: ROSSARI
Dear Sir/Madam,
Sub: Outcome of Board Meeting held on Saturday, July 18, 2026
Ref.: Compliance with Regulation 30 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015.
With regards to the captioned matter and in compliance with the Securities and Exchange Board of
India (“SEBI”) (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “Listing
Regulations”), as amended, this is to inform that at the meeting of the Board of Directors of
the Company (“the Board”) which commenced at 12:00 noon and concluded at 02:00 p.m. today
i.e. Saturday, July 18, 2026, the Board have inter alia approved the following:
1. Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30,
2026
Copy of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30,
2026 are enclosed herewith.
The aforesaid results were reviewed by the Audit Committee and subsequently, approved and taken
on record by the Board of Directors of the Company. We would further like to inform that the
Statutory Auditors of the Company have subjected the aforesaid results to “Limited Review” and
the same is enclosed herewith.
2. Grant of Options under Rossari Employee Stock Option Plan - 2019.
Pursuant to Regulation 30 of the Listing Regulations and ratification of the Rossari Employee Stock
Option Plan - 2019 (“ESOP 2019”) by the Members of the Company on April 17, 2021, the Board
has approved grant of 4000 Stock Options under ESOP 2019.
Further, detailed intimation as per Regulation 30 of the Listing Regulations for Grant of Options
under ESOP 2019, are enclosed as Annexure - I.
ROSSARI BIOTECH LIMITED
(An ISO 9001:2015 & 14001:2015 Certified Company) (CIN: L24100MH2009PLC194818)
Regd. Office: Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai -400079, Maharashtra, India. T: +91-22-6123 3800
Factory : Plot No. 10 & 11, Survey No. 90/1/10 & 90/1/11/1, Khumbharwadi, Village Naroli, Silvassa-396235, Dadra & Nagar Haveli (U.T.), India. T: 0260-669 3000
: Plot No. D3-24-2 & D3-24-3, Phase Ill, GIDC Dahej, Village Galenda, Taluka Vagra, Bharuch, Gujarat -392130, India. T: +91-2641-661621
@ (@
info@rossari.com www.rossari.com
HOME, PERSONAL CARE AND PERFORMANCE CHEMICALS TEXTILE SPECIALITY CHEMICALS ANIMAL HEALT H AND NUTRITION
ROSSARI
making you more competitive
3. Allotment of Equity Shares under the Rossari Employee Option Plan - 2019
With reference to the in-principle approval received from BSE Limited Letter Ref. No.
DCS/FL/MJ/ESOP-IP/1257/2021-22 dated May 25, 2021 and National Stock Exchange of India
Limited Letter Ref. No. NSE/LIST/26888 dated May 28, 2021 for issue and allotment of 1500000
Equity Shares of Rs. 2/- each to be issued under ESOP 2019, the Board approved the allotment of
2500 Equity Shares of Rs. 2/- each fully paid to the grantees on exercise of the options granted to
them pursuant to ESOP 2019.
Said equity shares shall rank pari passu, in all respects with the existing equity shares of the
Company. Consequent, to the allotment of the aforesaid equity shares, the issued and the paid-up
equity share capital of the Company stands increased to Rs. 11,07,88,232 consisting of 55394116
Equity Shares of Rs. 2/- each.
Details as required under the SEBI (Share Based Employee Benefits and Sweat Equity)
Regulations, 2021 are enclosed as Annexure - II.
4. Transfer of 100% shareholding of Rossari International Limited Company to Rossari
(Singapore) Pte. Ltd.
The Board has approved the transfer of the Company's 100% shareholding in Rossari International
Limited Company (RILC), a wholly owned subsidiary of the Company, to Rossari (Singapore) Pte.
Ltd. (Rossari Singapore), which is also a wholly owned subsidiary of the Company.
The proposed transfer is undertaken as part of an internal group restructuring exercise aimed at
bringing all overseas subsidiaries of the Company under a single, existing overseas investment
subsidiary, thereby establishing a common holding platform. The restructuring is intended to
simplify overseas regulatory reporting into a single reporting line.
The transaction is subject to: (i) Execution of a Share Purchase Agreement between the relevant
parties; and (ii) Receipt of requisite approvals from the relevant authorities in the Kingdom of Saudi
Arabia.
On completion of the transaction, RILC, shall become wholly owned subsidiary of Rossari
Singapore and a step-down wholly owned subsidiary of the Company. As the transaction is a
transfer of shareholding between holding and wholly owned subsidiary of the Company, there is no
change in the ultimate beneficial ownership of RILC, and the transaction is not expected to have
any material impact on the Company's consolidated financial position or operations.
Details required pursuant to Regulation 30 of the Listing Regulations read with SEBI Master
Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as
Annexure - III.
ROSSARI BIOTECH LIMITED
(An ISO 9001:2015 & 14001:2015 Certified Company) (CIN: L24100MH2009PLC194818)
Regd. Office: Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai -400079, Maharashtra, India. T: +91-22-6123 3800
Factory : Plot No. 10 & 11, Survey No. 90/1/10 & 90/1/11/1, Khumbharwadi, Village Naroli, Silvassa-396235, Dadra & Nagar Haveli (U.T.), India. T: 0260-669 3000
: Plot No. D3-24-2 & D3-24-3, Phase Ill, GIDC Dahej, Village Galenda, Taluka Vagra, Bharuch, Gujarat -392130, India. T: +91-2641-661621
@ (@
info@rossari.com www.rossari.com
HOME, PERSONAL CARE AND PERFORMANCE CHEMICALS TEXTILE SPECIALITY CHEMICALS ANIMAL HEALT H AND NUTRITION
ROSSARI
making you more competitive
The same may please be taken on record and suitably disseminated to all concerned.
Thanking You,
Yours Sincerely,
For Rossari Biotech Limited
Parul Gupta
Company Secretary & Head - Legal
Membership No.: A38895
Encl.: as above
ROSSARI BIOTECH LIMITED
(An ISO 9001:2015 & 14001:2015 Certified Company) (CIN: L24100MH2009PLC194818)
Regd. Office: Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai -400079, Maharashtra, India. T: +91-22-6123 3800
Factory : Plot No. 10 & 11, Survey No. 90/1/10 & 90/1/11/1, Khumbharwadi, Village Naroli, Silvassa-396235, Dadra & Nagar Haveli (U.T.), India. T: 0260-669 3000
: Plot No. D3-24-2 & D3-24-3, Phase Ill, GIDC Dahej, Village Galenda, Taluka Vagra, Bharuch, Gujarat -392130, India. T: +91-2641-661621
@ (@
info@rossari.com www.rossari.com
HOME, PERSONAL CARE AND PERFORMANCE CHEMICALS TEXTILE SPECIALITY CHEMICALS ANIMAL HEALT H AND NUTRITION
ROSSARI
making you more competitive
Annexure-I
Detailed intimation as per Regulation 30 of the Listing Regulations
Sr. Particulars Details
1. Brief details of options granted Grant of 4000 Options to eligible employees.
2. Whether the scheme is in terms of Yes, the Rossari Employee Stock Option Plan - 2019
SEBI (Share based Employee (ESOP 2019) has been formulated and adopted by the
Benefits and Sweat Equity) Company in terms of the Securities and Exchange Board
Regulations, 2021 (if applicable) of India (Share Based Employee Benefits) Regulations,
2014.
3. Total number of shares covered 4000 Equity Shares of the face value Rs. 2/- each (As per
by these options terms, each Option will be converted into one Equity
Share of the Company).
4. Pricing Formula/ Exercise Price As per the ESOP 2019, the exercise price of the Options
will be decided by the Board/N
[Showing first 8,000 characters — download PDF for full document]